デフォルト表紙
市場調査レポート
商品コード
1529970

医療償還市場:請求額別、支払者別、サービスプロバイダー別、地域別

Healthcare Reimbursement Market, By Claim, By Payer, By Service Provider, By Geography


出版日
ページ情報
英文 174 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療償還市場:請求額別、支払者別、サービスプロバイダー別、地域別
出版日: 2024年07月03日
発行: Coherent Market Insights
ページ情報: 英文 174 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の医療償還市場の2024年の市場規模は231億1,000万米ドルと推定され、2031年には711億米ドルに達すると予測され、2024~2031年のCAGRは17.4%です。

レポート範囲 レポート詳細
基準年 2023年 2024年の市場規模 231億1,000万米ドル
実績データ 2019~2023年 予測期間 2024~2031年
予測期間2024~2031年のCAGR 17.40% 2031年の金額予測 711億米ドル
図.医療償還市場シェア(%)、2024年、地域別
Healthcare Reimbursement Market-IMG1

医療償還とは、医師や病院などの医療提供者が患者や保険会社から受け取る決済を指します。診療報酬は、治療中に発生した費用を補填することで、患者が質の高い医療を受けられるようにします。高齢者人口の増加、慢性疾患の増加、医療保険普及率の上昇、新たな規制改革の登場といった要因が、予測期間中の市場成長を促進する可能性があります。しかし、不明瞭な償還政策や公的部門における資金提供の減少は、市場成長の妨げとなる可能性があります。

市場力学:

世界の医療償還市場の成長は、慢性疾患の有病率の増加、高齢者人口の増加、医療費の上昇、発展途上国における民間医療保険の拡大、国民皆保険を推進する政府による有利な償還枠組みの採用などの要因によってもたらされます。推定によると、慢性疾患は2016年に1億3,300万人の米国人を罹患させ、年間医療コストに3兆7,000億米ドルをもたらしました。このような高コストにより、医療へのアクセスを向上させることを目的とした有利な償還政策が展開されています。しかし、償還政策には政策やプロセスが不明確であるという課題があり、その結果、償還率が低下している国もあります。また、公的部門における資金不足や予算上の制約も市場成長の妨げとなる可能性があります。一方、償還プロセスのデジタル化と新規参入は、予測期間中に市場成長の機会をもたらす可能性があります。

本調査の主要特徴

  • -本レポートは、世界の医療償還市場を詳細に分析し、2023年を基準年とした予測期間(2024~2031年)の市場規模(10億米ドル)と年間平均成長率(CAGR%)を提供しています。
  • また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の医療償還市場の主要企業プロファイルを掲載しています。
  • 本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • 世界の医療償還市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
  • 利害関係者は、世界の医療償還市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • 一貫型機会マップ(COM)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 影響分析
  • 市場動向
  • 規制シナリオ
  • 買収と提携のシナリオ
  • 資金調達と投資
  • PEST分析
  • ポーターの分析

第4章 世界の医療償還市場-コロナウイルス(COVID-19)パンデミックの影響

  • 全体的な影響
  • 政府の取り組み
  • COVID-19による市場への影響

第5章 世界の医療償還市場、請求額別、2019~2031年(10億米ドル)

  • イントロダクション
  • 全額
  • 一部

第6章 世界の医療償還市場、支払者別、2019~2031年(10億米ドル)

  • イントロダクション
  • 民間保険会社
  • 公的支払者

第7章 世界の医療償還市場、サービスプロバイダー別、2019~2031年(10億米ドル)

  • イントロダクション
  • 個人医院
  • 病院・クリニック
  • 診断ラボ
  • 医療機器と医療用品
  • その他

第8章 世界の医療償還市場、地域別、2019~2031年(10億米ドル)

  • イントロダクション
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東

第9章 競合情勢

  • 企業プロファイル
    • UnitedHealth Group
    • Aviva
    • Allianz
    • CVS Health Corporation
    • Bupa
    • Aon plc
    • Cigna Corporation
    • Centene Corporation
    • Anthem, Inc.
    • Blue Cross Blue Shield Association(BCBSA)
    • Humana Inc.
    • WellCare Health Plans, Inc.
    • Medicaid Services(CMS)
    • Health Care Service Corporation(HCSC)
    • Anthem Blue Cross Blue Shield
    • Molina Healthcare, Inc.
    • Kaiser Permanente

第10章 アナリストの推奨事項

  • 隆盛と衰退
  • 一貫型機会マップ

第11章 参考文献と調査手法

  • 参考文献
  • 調査手法
目次
Product Code: CMI7108

Global healthcare reimbursement market is estimated to be valued at USD 23.11 Bn in 2024 and is expected to reach USD 71.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 17.4% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 23.11 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 17.40% 2031 Value Projection: US$ 71.10 Bn
Figure. Healthcare Reimbursement Market Share (%), By Region 2024
Healthcare Reimbursement Market - IMG1

Healthcare reimbursement refers to the payment received by healthcare providers like physicians, hospitals and others from either patients or insurance companies. Reimbursements enable access to quality care for the patients by compensating the costs incurred during treatment. Factors such as rising geriatric population, rising chronic diseases, increasing health insurance penetration and emergence of new regulatory reforms can drive the market growth during the forecast period. However, unclear reimbursement policies and reduced funding in the public sector can hamper the market growth.

Market Dynamics:

Global healthcare reimbursement market growth is driven by factors such as increasing prevalence of chronic diseases, growing geriatric population, rising healthcare costs, expansion of private health insurance across developing nations and introduction of favorable reimbursement frameworks by governments promoting universal healthcare. According to estimates, chronic diseases affected 133 million Americans in 2016 and contributed to US$ 3.7 trillion in annual healthcare costs. Such high costs have led to the development of favorable reimbursement policies that aim to increase access to care. However, reimbursement landscape present challenges in terms of unclear policies and processes, thus, resulting in declining reimbursement rates in some countries. Lack of funding and budgetary constraints in the public sector can also hamper the market growth. Meanwhile, digitization of reimbursement processes and entry of new players in the market can offer opportunities for market growth during the forecast period.

Key features of the study

  • -This report provides in-depth analysis of the global healthcare reimbursement market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global healthcare reimbursement market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include UnitedHealth Group, Aviva, Allianz, CVS Health, BNP Paribas, Aetna, Nippon Life Insurance, WellCare Health Plans, AgileHealthInsurance and Blue Cross Blue Shield Association
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global healthcare reimbursement market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare reimbursement market.

Detailed Segmentation-

  • By Claim
    • Fully paid
    • Underpaid
  • By Payer
    • Private Payers
    • Public Payers
  • By Service Provider
    • Physician office
    • Hospitals & Clinics
    • Diagnostic Laboratories
    • Medical Equipment & Supplies
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • UnitedHealth Group
    • Aviva
    • Allianz
    • CVS Health Corporation
    • Bupa
    • Aon plc
    • Cigna Corporation
    • Centene Corporation
    • Anthem, Inc.
    • Blue Cross Blue Shield Association (BCBSA)
    • Humana Inc.
    • WellCare Health Plans, Inc.
    • Medicaid Services (CMS)
    • Health Care Service Corporation (HCSC)
    • Anthem Blue Cross Blue Shield
    • Molina Healthcare, Inc.
    • Kaiser Permanente

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Claim
    • Market Snapshot, By Payer
    • Market Snapshot, By Service Provider
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Healthcare Reimbursement Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Healthcare Reimbursement Market, By Claim, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Fully paid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Underpaid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Healthcare Reimbursement Market, By Payer, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Private Payers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Public Payers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Healthcare Reimbursement Market, By Service Provider, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Physician office
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Hospitals & Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Diagnostic Laboratories
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Equipment & Supplies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Healthcare Reimbursement Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Claim, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Claim, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Claim, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Claim, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Claim, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Claim, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Payer, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • UnitedHealth Group
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Aviva
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Allianz
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • CVS Health Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bupa
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Aon plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cigna Corporation
    • Centene Corporation
    • Anthem, Inc.
    • Blue Cross Blue Shield Association (BCBSA)
    • Humana Inc.
    • WellCare Health Plans, Inc.
    • Medicaid Services (CMS)
    • Health Care Service Corporation (HCSC)
    • Anthem Blue Cross Blue Shield
    • Molina Healthcare, Inc.
    • Kaiser Permanente

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact